X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-02 | VTYX | Nuss John | Chief Scientific Officer | S - Sale | $1.07 | -1,887 | 467,226 | 0% | -$2,019 | ||||||
2024-12-27 | VTYX | Nuss John | Chief Scientific Officer | S - Sale | $2.36 | -21,119 | 464,582 | -4% | -$49,841 | ||||||
D | 2024-12-19 | VTYX | Nuss John | Chief Scientific Officer | S - Sale+OE | $2.26 | -13,161 | 485,701 | -3% | -$29,682 | |||||
2024-04-02 | VTYX | Nuss John | Chief Scientific Officer | S - Sale | $5.40 | -1,651 | 264,998 | -1% | -$8,921 | ||||||
2023-12-20 | VTYX | Nuss John | Chief Scientific Officer | S - Sale | $2.12 | -17,628 | 262,118 | -6% | -$37,334 | ||||||
D | 2023-10-03 | VTYX | Nuss John | Chief Scientific Officer | S - Sale+OE | $29.99 | -10,000 | 244,815 | -4% | -$299,933 | |||||
D | 2023-09-05 | VTYX | Nuss John | Chief Scientific Officer | S - Sale+OE | $32.60 | -10,000 | 244,815 | -4% | -$325,960 | |||||
D | 2023-08-03 | VTYX | Nuss John | Chief Scientific Officer | S - Sale+OE | $35.60 | -10,000 | 244,815 | -4% | -$355,986 | |||||
D | 2023-07-03 | VTYX | Nuss John | Chief Scientific Officer | S - Sale+OE | $39.58 | -20,000 | 244,815 | -8% | -$791,637 | |||||
D | 2023-06-05 | VTYX | Nuss John | Chief Scientific Officer | S - Sale+OE | $34.35 | -10,000 | 244,815 | -4% | -$343,467 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |